Context: Thyroid dysgenesis may be associated with lossof-function mutations in the thyrotropin receptor (TSHR) gene. Objectives: The aim of this study was to characterize a novel TSHR gene variant found in one patient harboring congenital hypothyroidism (CH) from a cohort of patients with various types of thyroid defects.
Introduction
Thyrotropin (TSH) exerts its effects on the thyroid cell by binding to specific receptors on the cell surface (1) . The thyrotropin receptor (TSHR) belongs to the superfamily of seven-transmembrane receptors that trigger signaltransduction pathways through their synergy with guanine-nucleotide-binding regulatory proteins (G proteins) (1) (2) (3) (4) . As such, they contain a canonical serpentine region containing seven transmembrane helices typical of rhodopsin-like glycoprotein hormone receptor (GPCRs), and a large (350-400 residues) amino-terminal ectodomain containing leucine-rich repeats, which is responsible for the high affinity and selective binding of the corresponding hormones (1) . The amino-terminal segment is responsible for high affinity binding of the hormones and recognition specificity (5) . The hinge region (HinR) is the least conserved GPCR portion and the most variable in size, between the extracellular leucine-rich repeat motif and the transmembrane helices (6) (7) (8) (9) (10) . The importance of this region for hormone binding, signal transduction, and receptor activation has been indicated in several studies; however, the hormone TSHR interaction mechanisms have yet to be completely understood (8) (9) (10) . The intramolecular transduction mechanism of the signal, by which binding of TSH to the extracellular region of the receptor is transduced via the membrane-spanning regions to the cytoplasmic compartment of the receptor that interact with the G proteins, is not well known. A current model for the activation of TSHR would examine a zone of discrete states characterized by different configurations (2, 3) .
In the frame of our discussion, it is worth noting that amino acid substitutions in the ectodomain of GPCRs might affect their function by modifying the electrostatic surface map of the variant receptor, thereby leading to a loss of specificity, or affinity through a shift on sialylated and sulfated carbohydrate structure (1, 11) .
Germline TSHR loss-of-function mutations in the TSHR gene have been involved as the molecular answer for TSH resistance and congenital hypothyroidism (CH) (OMIM no. 275200). Subjects with a heterozygous loss of function mutation appear to have a dominant transmission of partial TSH resistance, which is attributed to intracellular entrapment, reduced maturation, and oligomerization between inactive mutants and the WT receptor (12) (13) (14) (15) (16) . Indeed, in the past years, many germline TSHR variants, culminating in amino acid substitutions have been discovered (12) . Two of these are located in the extracellular domain of the receptor (p.D36H and p.P52T), and one is located in the intracellular domain (p.D727E) (17) (18) (19) . The TSHR variant p.D727E allele associated with lower levels of plasma TSH without effect on FT 4 levels, point toward a higher sensitivity of the variant compared with the WT TSHR. This is because less TSH is needed to achieve normal FT 4 levels, as reported in two studies (20, 21) . However, others have not been able to reproduce such data (22, 23) . Despite the fact that the p.P52T and p.D36H polymorphisms have not been correlated with modifications in serum TSH levels in healthy individuals, conflicting data are also available regarding the response of the extracellular domain p.P52T variant to TSH stimulation (24, 25) .
In the current study, we report a novel germline variant, p.S304R, located in the hinge region (HinR) of the extracellular domain of the TSHR, which is present in heterozygocity in a patient with congenital hypothyroidism. We examined the functional properties of this variant by transient expression in HEK293 cells, with particular interest in the effect on binding ability, cAMP production, and glycosilation profile. The knowledge about the contribution of systematically conserved residues within the TSHR HinR to hormone binding is very important in the further clarification of their precise functional importance in hormone-receptor interactions.
Materials and methods

Subjects
We enrolled 118 patients with CH, including 45 with familial and 73 with sporadic diseases recruited from the French Neonatal Screening Program, along with their family members ( Table 1 ). The thyroid gland was normal in size and position in 23 of these patients; 92 patients had hypoplasia (n = 25), hemithyroid agenesis (n = 25), 
TSHR sequencing
Genomic DNA was extracted from whole blood, and 10 exons of the TSHR gene were amplified in 15 separate PCRs (26) . PCR products were purified using the Qiaquick PCR purification kit (QIAGEN, Hilden, Germany) and sequenced using the ABI PRISM Dye Terminator cycle sequencing Ready Reaction kit (PE Applied Biosystems, Foster City, CA, USA) according to the manufacturers' instructions. Sequences were analyzed using Sequence Navigator Software (PE Applied Biosystems Division, Perkin Elmer, Foster City, CA, USA). Bidirectional sequencing was performed using an automated cycle sequencer (ABI) Prism 3100 Genetic Analyzer (Applied Biosystems, Vernon Hills, IL, USA). Sequence alterations were examined in the context of the open reading frame to determine whether the alteration changed the corresponding amino acid. A total of 100 normal individuals were screened for the identified sequence alterations. Mutations in other candidate genes (PAX8, NKX2.1, NKX2.5) were excluded.
Annotation of the human TSHR protein
Genbank accession no. NP_16473 (www.ncbi.nlm.nih.gov) was used for the human TSHR protein reference. Exon positions were calculated from the annotation at the University of California, Santa Cruz, Genome Browser (http://genome.ucsc.edu).
Prediction of TSHR orthologs and alignment with human TSHR sequence
The corresponding proteins for each of the 11 non-human species (Pan troglodydes, Macaca mulatta, Rattus norvegicus, Mus musculus,
Bos taurus, Dasypus novemcinctus, Monodelphis domestica, Gallus gallus, Xenopus tropicalis, Takifugu rubripes and Orysias latipes)
used in this study were obtained as described here. First, the genomic sequence was obtained from all species; second, protein predictions were obtained for each DNA sequence using GENSCAN software (http://bioweb.pasteur.fr/seqanal/interfaces/genscan-simple. html) (27) and default parameters; third, results from GENSCAN were compared with the NP_16473 reference sequence using BLAST (www.ncbi.nlm.nih.gov) (28) to identify TSHR orthologs; and fourth, TSHR protein orthologs were aligned to the human reference using CLUSTALW (http://clustalw.genome.ad.jp) (29) . Accession numbers corresponding to all sequences used in this study are provided under solicitation.
TSHR-S304R functional studies
Western-blot analysis and 125 I-TSH binding experiments were performed as previously described (30) . Accumulation of cAMP was measured using the cAMP dynamic 2 kit (Cisbio Bioassays, Bagnolssur-Cèze, France) according to the manufacturer's instructions. Transient HEK293-cell transfection with plasmid-encoded TSHR-WT or TSHR-S304R was performed, and 48 h later the cells were washed once with phosphate buffer saline (PBS) and detached with PBS-ETDA 5 mM. The cells were then resuspended in stimulation buffer (Krebs buffer with 0.28 M sucrose) and plated in 384-well plates. The cells were stimulated for 30 min with various TSH concentrations in stimulation buffer, which was upplemented with 0.5 mM of IBMX. After stimulation, fluorophore d2-labeled cAMP and anti-cAMP antibody conjugated to cryptate were added and incubated for 1 h at room temperature, and the plate was read at 620 nm and 665 nm using the PARADIGM™ Detection Platform (Beckman Coulter, Brea, CA, USA). Data were analyzed using GraphPad Prism Software (GraphPad, San Diego, CA, USA).
Results
Genetic screening and clinical phenotype
The family pedigree has been previously described (31) . Direct TSHR gene sequencing identified one different heterozygous TSHR variant (p.S304R) in three family members: the proposistus, his father, and the older brother (Figures 1 and 2A) . The affected boy is the second child of healthy, nonconsanguineous parents and was born at term, following an uncomplicated pregnancy and delivery, with a weight of 3.400 kg. Neonatal TSH screening showed a TSH level of 155 μU/mL (normal < 20 μU/mL) and an FT 4 level of 0.8 ng/dL (normal 0.8-1.8). He presented jaundice, mild hypotonia, and a large posterior fontanelle. LT-4 therapy was started at 13 days of age. By 18 days of age, a 123 I scintigraphy showed a hypoplastic gland in normal position (Figure 1 ). The parents were clinically unaffected, but biological investigations showed moderate TSH elevation in the father (TSH, 6.2 μU/mL; normal: 0.4-4.5) with an FT 4 level of 1.0 ng/dL (normal: 0.8-1.8). The propositus' brother had a normal thyroid gland at ultrasound and normal thyroid function tests with a TSH of 2.5 μU/mL (normal: 0.4-4.5). Subsequent analysis of the direct family members revealed that his paternal grandmother had medical history of a mild high TSH of 9.4 μU/mL (normal: 0.4-4.5). By 5 years old, thyroid ultrasound revealed a very hypoplastic thyroid gland. Clinical assessment to date reveals normal growth and development. All family members were studied for mutation in other known candidate genes for thyroid dysgenesis. The patient's father and brother have a normal PAX8 coding sequence, and there were no other TSHR sequence variations among the members of this family. The propositus was heterozygous for the previously reported p.R31C PAX8 mutation as previously reported in other studies (31) (32) (33) . The p.S304R variant was not found in 100 normal individuals.
Ortholog alignment
Our analysis rests on the idea that the differences in standard physicochemical properties between the "wildtype" amino acid and the missense variant are the root cause of functional impairment, and that evolutionary variation among orthologs in the affected position is a sample of the physicochemical properties tolerated at that position. We first built a multiple alignment of orthologs with ClustalW2 ( Figure 1 ) (34); paralogs were excluded to avoid including evolutionary variation that specified functional differences. We have predicted orthologous TSHR protein sequences from the genomic sequences of 11 non-human vertebrate species, including two primates, one artiodactyl, one carnivore, three rodents, one bird, one amphibian and two teleosts species, successfully aligning all to the human reference ( Figure 1 ). The corresponding proteins for each of the abovementioned species were identified and aligned ( Figure 1 ). As expected, maximal identity was observed between the reference (human) and the most recently diverged species, the non-human primates. Similarity decreased as we progressed through the mammalian radiation to greater evolutionary distances, and was at its lowest as we reached the avian and teleost species.
Functional studies of TSHR-S304R
Substitution of an arginine for serine 304 modified the consensus sequence of an N-glycosylation site (NXS/T), changing the . The glycosylation status of the S304R-mutated TSHR gene (S304R-TSHR) was determined by Western blot, with an antibody directed against the extracellular domain of TSHR. In protein extracts from cells transiently expressing WT-TSHR, this antibody revealed two bands corresponding to the high-mannose form at 95 kDa and to the alpha subunit at 56 kDa (35) . After deglycosylation by endoglycosidase F (EndoF), which removed all complex sugars from the N-glycosylation site, two bands appeared, at 80 and 37 kDa, respectively ( Figure 2B ). In membrane proteins extracted from HEK293 cells transiently expressing S304R-TSHR, two bands were also detected, but their molecular weights were slightly lower than those observed for WT-TSHR ( Figure 2B ). These differences between S304R-TSHR and WT-TSHR disappeared after EndoF treatment. Therefore, the S304R substitution disrupted N-glycosylation of asparagine 302 ( Figure 2B ). Functional analyses showed that the S304R substitution affected neither TSH binding to TSHR nor adenylatecyclase pathway activation, thus indicating that neither N-glycosylation of N302 nor 302 NES 304 sequence was critical for TSHR function (Figures 2C and 2D ).
Discussion
In a CH patient, we identified a novel heterozygous germline point mutation, at codon 304, which resulted in the substitution of a serine for an arginine (p.S304R) of the TSHR. The mutant receptor was transiently expressed in HEK293 cells and caused equivalent activation of the cAMP pathway when compared with the WT TSHR ( Figure  2) . The p.S304R variant was identified in only one of the 440 chromosomes analyzed in this cross-sectional study and control population. Therefore, this variation is not considered polymorphism but may be considered a rare sequence variant instead. The analysis of amino acid residue serine in the position 304 of the protein of the TSHR gene showed conservation among Homo sapiens, Macaca mulatta, Rattus norvegicus, Mus musculus, Bos taurus, Dasypus novemcinctus and Monodelphis domestica (Figure 1) . However, although mutational analyses may be significantly enhanced by deep evolutionary sequence comparisons, they may not account for all sources of functional constraint and phenotypic impact.
The TSHR ectodomain can be subdivided into leucinerich repeat (LRR) and the HinR, which links the LRR with the serpentine domain and is assumed to be represented by amino acids placed between positions 280 and 410, which contain multiple possible TSH binding sites (9) . Therefore, it was likely that the change of a polar hydrophilic S304 into a positive charged arginine residue disrupted the HinR structure, leading to a reduction in the receptor binding capacity. The p.S304R variant is located in a glycosilation HinR position within the onset of the of the cysteine box 2/3 linker region, which is known to be responsible to connect the N-and C-terminally located cysteine boxes [cysteine box 2 (C-b2) and Cysteine box 3 (C-b3)] (36). The value of the C-b2/3 linker in the maintenance of the signaling competence of the receptor has been revealed by several studies (5, 36) . More specifically, the role for the serine in the 304 position has been explored and its substitution for alanine (p.S304A mutant) had 32% reduction in the expression and a slight but significant impairment (15%) in binding both bovine TSH (bTSH) and TR1401 (a human TSH analog) (10) . Nevertheless, another study confirmed that p.S304A had decreased cell surface expression and transfection efficiency by FACS analysis, but the basal and stimulated cAMP accumulation were normal compared with WT receptor (36) .
Actually, the cysteine box 2/3 linker region and C-terminal portion of HinR harbor other previously described, naturally occurring inactivating mutations (p.R310C, p24X, p.C390W, p.D403N, and p.D410N), and site-directed mutagenesis studies have demonstrated that even the replacement of a single amino acid residue (e.g., p24X, p.C390W, and p.D403N) can severely impair the expression of a functional receptor protein (26, (37) (38) (39) (40) (41) (42) (43) (Table 2) . Most described patients with a TSHR mutation within the HinR have a thyroid of reduced size, suggesting that this region plays an important role in the signal transduction and, consequently, in the thyroid gland growth (Table 2 ) (26, (37) (38) (39) (40) (41) (42) (43) (44) (45) 47) .
Meanwhile, the mutations p.R310C and p.C390W are related with impaired binding and cAMP generation, confirming the hypothesized inhibitory effect of the extracellular domain on a noisy transmembrane; this also explains the compensated TSH resistance in affected patients. On the one hand, the mutation D410N has been reported to be associated with normal binding but defective cAMP generation, and such findings confirm the role of the HinR in conveying the signal from the extracellular domain to the serpentine domain. On the other hand, our functional analysis could express cDNA for the WT and the p.S304R receptor variant in HEK293 cells. The 125 I-thyrotropin binding capacity analysis also showed that both forms exhibited similar specific and saturable binding of thyrotropin and the amount of expressed cells on the surface (Figure 2B-D) . Further, the aditional functional characterization of the TSHR-S304R variant showed that the absence of one N-glycosylation site did not modify receptor function ( Figure 2B ). In this context, the p.S304R hinge variant does not seem to be functionally important, and the described dysgenetic phenotype would only be explained by the heterozygous p.R31C mutation, which was exclusively found in the propositus patient. The deleterious effect of PAX8 mutation has already been demonstrated (33) . We can assume that the wearing 2 mutations on the PAX8 and TSHR synergize default size and functional thyroid.
Understanding the structure and function of the HinR is an important step in achieving a complete picture of the necessary mechanisms for the TSHR activation and signaling. Recent reports have shown that the HinR is not only a scaffold for maintaining binding of the glycoprotein hormones, but may also work as an important signal transmitter for TSH-induced activation.
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